Shares of Solventum Corp. SOLV advanced 1.74% to $66.63 Thursday, on what proved to be an all-around positive trading session ...

(Reuters) -3M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products. The Minnesota-based company is one of ...

Healthcare solutions provider Solventum (NYSE:SOLV) announced in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion.

SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency ...

Solventum Corp (SOLV) reports a promising start to 2025 with robust sales growth and strategic investments, despite facing significant tariff headwinds.

The health care company posted revenue of $2.07 billion in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $2 billion. Solventum expects full-year earnings in ...

Solventum Corp. closed 22.15% below its 52-week high of $85.92, which the company reached on February 26th.

Reported sales increased 2.6%; organic sales increased 4.3% Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5% ST. PAUL, Minn., May ...

SOLVENTUM ($SOLV) is expected to release its quarterly earnings data on Thursday, May 8th after market close, per Finnhub. Analysts are expecting revenue of ...

In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) stands against other best new stocks to buy according to billionaires. International IPO activity during the ...

7 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...